Skip to content
National Health Commission should monitor all gene-editing centers and IVF clinics in China to ensure trials are in line with regulations.
A national registry dedicated to clinical trials involving cell technologies should be established to pro
mote greater transparency, they said, so that before a trial begins scientists would need to pass an
ethics review and provide a list of names of all participating scientists and institutions.
Universities and research institutes should strengthen education and
training in bioethics and scientific and medical professionalism, covering research sci
entists and students of science, medicine and the humanities at all levels, they said.
In addition, more efforts should be undertaken to eliminate prejudice against people wi
th disabilities, which exists in the minds of some scholars, they said. Following the gene-edited baby incid
ent, government departments have vowed to improve supervision, and new regulations are being made or revised.
ns in February for the clinical application of new biomedical technologies, stipulating that clini
cal research that involves human trials, including gene editing, stem cells, organ transplants be
tween species and assisted reproductive technologies, must secure the approval of the commission in advance.
Under the draft, which is yet to be adopted, violators may face punishments including fines, revocation of business permits or criminal charges.
The commission this year will complete its revision of an existing r
egulation on ethical inspection of human-related biomedical research that was adopted in 2016.
Authorities are also considering establishing a national ethics co
mmittee that supervises life science technologies and researchers to ensure compliance wi
th ethical standards, Huang Jiefu, former vice-minister of health, told China Daily in an earlier interview.